HUTCHMED (HCM) Competitors $15.80 -0.09 (-0.54%) As of 02:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCM vs. RDY, ASND, VTRS, QGEN, BBIO, ROIV, ELAN, VRNA, MRNA, and RVMDShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Viatris (VTRS), QIAGEN (QGEN), BridgeBio Pharma (BBIO), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Moderna (MRNA), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Its Competitors Dr. Reddy's Laboratories Ascendis Pharma A/S Viatris QIAGEN BridgeBio Pharma Roivant Sciences Elanco Animal Health Verona Pharma PLC American Depositary Share Moderna Revolution Medicines Dr. Reddy's Laboratories (NYSE:RDY) and HUTCHMED (NASDAQ:HCM) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Do insiders & institutionals believe in RDY or HCM? 3.9% of Dr. Reddy's Laboratories shares are held by institutional investors. Comparatively, 8.8% of HUTCHMED shares are held by institutional investors. 2.0% of Dr. Reddy's Laboratories shares are held by company insiders. Comparatively, 3.6% of HUTCHMED shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts prefer RDY or HCM? Dr. Reddy's Laboratories currently has a consensus price target of $16.95, indicating a potential upside of 19.83%. HUTCHMED has a consensus price target of $20.88, indicating a potential upside of 32.16%. Given HUTCHMED's higher possible upside, analysts plainly believe HUTCHMED is more favorable than Dr. Reddy's Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dr. Reddy's Laboratories 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.80HUTCHMED 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is RDY or HCM more profitable? Dr. Reddy's Laboratories has a net margin of 16.99% compared to HUTCHMED's net margin of 0.00%. Dr. Reddy's Laboratories' return on equity of 17.25% beat HUTCHMED's return on equity.Company Net Margins Return on Equity Return on Assets Dr. Reddy's Laboratories16.99% 17.25% 11.63% HUTCHMED N/A N/A N/A Which has more volatility and risk, RDY or HCM? Dr. Reddy's Laboratories has a beta of 0.32, meaning that its stock price is 68% less volatile than the S&P 500. Comparatively, HUTCHMED has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Does the media prefer RDY or HCM? In the previous week, HUTCHMED had 1 more articles in the media than Dr. Reddy's Laboratories. MarketBeat recorded 3 mentions for HUTCHMED and 2 mentions for Dr. Reddy's Laboratories. Dr. Reddy's Laboratories' average media sentiment score of 1.22 beat HUTCHMED's score of 1.02 indicating that Dr. Reddy's Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dr. Reddy's Laboratories 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HUTCHMED 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, RDY or HCM? Dr. Reddy's Laboratories has higher revenue and earnings than HUTCHMED. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDr. Reddy's Laboratories$3.81B3.10$663M$0.6621.43HUTCHMED$630.20M4.37$37.73MN/AN/A SummaryDr. Reddy's Laboratories beats HUTCHMED on 9 of the 15 factors compared between the two stocks. Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.75B$3.07B$5.65B$10.26BDividend YieldN/A2.36%5.68%4.61%P/E RatioN/A20.6875.7026.05Price / Sales4.37397.57514.05168.79Price / Cash55.6745.9137.5661.52Price / Book3.579.6212.876.29Net Income$37.73M-$52.73M$3.29B$270.94M7 Day Performance-9.48%0.59%-0.33%-0.30%1 Month Performance-0.85%6.27%3.77%6.20%1 Year Performance-9.69%18.55%68.18%28.32% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMED3.0258 of 5 stars$15.80-0.5%$20.88+32.2%-8.5%$2.75B$630.20M0.001,811Positive NewsAnalyst DowngradeRDYDr. Reddy's Laboratories2.8902 of 5 stars$14.64-0.2%$16.95+15.8%-9.3%$12.24B$3.81B22.1727,811Positive NewsASNDAscendis Pharma A/S2.8492 of 5 stars$194.62-0.5%$244.36+25.6%+33.4%$11.97B$393.54M-37.721,017VTRSViatris2.0044 of 5 stars$9.60-3.6%$10.40+8.3%-15.2%$11.61B$14.74B-3.3132,000News CoveragePositive NewsHigh Trading VolumeQGENQIAGEN4.3146 of 5 stars$45.39+0.2%$49.69+9.5%+3.2%$10.07B$1.98B26.825,765BBIOBridgeBio Pharma4.541 of 5 stars$51.47+0.5%$63.94+24.2%+103.7%$9.79B$221.90M-12.58400Positive NewsROIVRoivant Sciences3.2819 of 5 stars$13.95-0.9%$17.67+26.6%+25.7%$9.61B$29.05M-19.93860Insider TradeAnalyst RevisionELANElanco Animal Health2.5918 of 5 stars$18.63+0.5%$17.33-6.9%+35.1%$9.21B$4.44B21.669,000News CoverageAnalyst ForecastVRNAVerona Pharma PLC American Depositary Share2.0039 of 5 stars$106.37-0.1%$109.00+2.5%+258.7%$9.17B$42.28M-107.4430Positive NewsMRNAModerna4.4982 of 5 stars$23.88+1.6%$41.81+75.1%-59.5%$9.15B$3.24B-3.175,800Trending NewsRVMDRevolution Medicines4.2703 of 5 stars$46.20-0.8%$73.67+59.5%-1.9%$8.70B$11.58M-10.27250 Related Companies and Tools Related Companies RDY Alternatives ASND Alternatives VTRS Alternatives QGEN Alternatives BBIO Alternatives ROIV Alternatives ELAN Alternatives VRNA Alternatives MRNA Alternatives RVMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCM) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCM Stock Alerts